Drugplain

Brimonidine Tartrate ophthalmic solution, 0.15% 1.5 mg/mL

Brimonidine Tartrate ophthalmic solution, 0.15% · SOLUTION/ DROPS · Alembic Pharmaceuticals Limited

No Recall History
Plain English

Brimonidine tartrate ophthalmic solution is a prescription eye drop used to treat redness of the eyes caused by ocular rosacea or other conditions. It works by narrowing blood vessels in the eye to reduce visible redness.

Key Facts

Brand Name
Brimonidine Tartrate ophthalmic solution, 0.15%
Generic Name
Brimonidine Tartrate ophthalmic solution, 0.15%
NDC Code (Product)
46708-661
Manufacturer
Alembic Pharmaceuticals Limited
Strength
1.5 mg/mL
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Marketing Status
Application #
ANDA215225
Marketing Start
03/29/2023

Recall History

No Recall History

Frequently Asked Questions

What is Brimonidine Tartrate ophthalmic solution, 0.15% used for?

Brimonidine tartrate ophthalmic solution is a prescription eye drop used to treat redness of the eyes caused by ocular rosacea or other conditions. It works by narrowing blood vessels in the eye to reduce visible redness.

Is Brimonidine Tartrate ophthalmic solution, 0.15% a controlled substance?

Brimonidine Tartrate ophthalmic solution, 0.15% is not classified as a controlled substance by the DEA.

What is the generic name for Brimonidine Tartrate ophthalmic solution, 0.15%?

The generic name for Brimonidine Tartrate ophthalmic solution, 0.15% is Brimonidine Tartrate ophthalmic solution, 0.15%. There are no other listed brand versions of Brimonidine Tartrate ophthalmic solution, 0.15%.

What is the NDC code for Brimonidine Tartrate ophthalmic solution, 0.15% 1.5 mg/mL?

The NDC (National Drug Code) for Brimonidine Tartrate ophthalmic solution, 0.15% 1.5 mg/mL is 46708-661, listed by Alembic Pharmaceuticals Limited.

Product NDC

46708-661

Package NDC

46708-661-05

Other Brimonidine Tartrate ophthalmic solution, 0.15% Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)